We are live on ! Find out more
Balyasny Asset Management

Balyasny Asset Management Portfolio holdings

AUM $77.1B
1-Year Est. Return 42.89%
This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+763.65%
AUM
$77.1B
AUM Growth
-$1.68B
Cap. Flow
-$2.68B
Cap. Flow %
-3.48%
Top 10 Hldgs %
16.75%
Holding
3,716
New
704
Increased
979
Reduced
1,056
Closed
911

Sector Composition

Rank Sector Weight
1 Technology 9.75%
2 Industrials 9.36%
3 Consumer Discretionary 8.52%
4 Healthcare 7.75%
5 Financials 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLBK icon
2876
Columbia Financial
CLBK
$1.13B
-15,142
Closed -$235K
CLPT icon
2877
ClearPoint Neuro
CLPT
$438M
-217,274
Closed -$2.97M
CLS icon
2878
Celestica
CLS
$36.6B
-87,664
Closed -$25.9M
CLX icon
2879
CALL
Clorox
CLX
$11.8B
-7,000
Closed -$706K
CMA
2880
CALL
DELISTED
Comerica
CMA
-12,700
Closed -$1.1M
CMA
2881
DELISTED
Comerica
CMA
-389,864
Closed -$33.9M
CMA
2882
PUT
DELISTED
Comerica
CMA
-4,000
Closed -$348K
CME icon
2883
CALL
CME Group
CME
$91.8B
-4,700
Closed -$1.28M
CME icon
2884
PUT
CME Group
CME
$91.8B
-3,500
Closed -$956K
COCO icon
2885
Vita Coco
COCO
$3.85B
-213,196
Closed -$11.6M
CODI icon
2886
Compass Diversified
CODI
$755M
-138,414
Closed -$664K
COHU icon
2887
Cohu
COHU
$2.26B
-30,192
Closed -$703K
COLM icon
2888
Columbia Sportswear
COLM
$3.25B
-220,271
Closed -$12.1M
CORT icon
2889
Corcept Therapeutics
CORT
$9.78B
-15,852
Closed -$552K
CORZ icon
2890
PUT
Core Scientific
CORZ
$6.59B
-566,600
Closed -$8.25M
CP icon
2891
Canadian Pacific Kansas City
CP
$81.1B
-10,235
Closed -$754K
CPA icon
2892
Copa Holdings
CPA
$5.65B
-258,251
Closed -$31.1M
CPNG icon
2893
CALL
Coupang
CPNG
$28.6B
-246,100
Closed -$5.81M
CPNG icon
2894
Coupang
CPNG
$28.6B
-48,093
Closed -$1.13M
CPNG icon
2895
PUT
Coupang
CPNG
$28.6B
-222,500
Closed -$5.25M
CRAI icon
2896
CRA International
CRAI
$1.12B
-8,195
Closed -$1.64M
CRGO icon
2897
Freightos
CRGO
$65.6M
-25,151
Closed -$57.3K
CRMD icon
2898
CorMedix
CRMD
$596M
-75,447
Closed -$877K
CRNX icon
2899
Crinetics Pharmaceuticals
CRNX
$8.87B
-233,197
Closed -$10.9M
CRSP icon
2900
CALL
CRISPR Therapeutics
CRSP
$4.6B
-71,200
Closed -$3.73M

Similar funds

Balyasny Asset Management's Q1 2026 Portfolio in Review

As of Q1 2026, Balyasny Asset Management held 3,716 positions worth $77.1B, down 2.1% from $78.8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Balyasny Asset Management withdrew a net $2.68B in Q1 2026, closing 911 positions and reducing 1,056 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $1.13B position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Balyasny Asset Management opened a new position in Silicon Laboratories worth $257M.

  • Balyasny Asset Management's largest Q1 2026 buy was Silicon Laboratories: 1,233,893 shares worth $257M.
  • Balyasny Asset Management added most to Meta Platforms (Facebook) in Q1 2026, an estimated $626M increase.
  • Balyasny Asset Management's biggest Q1 2026 reduction was Microsoft, cutting an estimated $502M.
  • Balyasny Asset Management fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $1.13B.
  • Balyasny Asset Management's ten largest holdings make up 17% of its $77.1B portfolio in Q1 2026.
  • Balyasny Asset Management opened 704 new positions and closed 911 in Q1 2026.
  • Balyasny Asset Management's portfolio value fell 2.1% quarter-over-quarter to $77.1B.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.